Masked Hypertension: Clinical Trials

17 trials for Masked Hypertension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 unknown, 6 completed, 1 not yet recruiting, 1 recruiting. 5 Not applicable, 4 Phase 4, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 2, Unknown 2, Recruiting 1
Phase 44Completed 2, Unknown 2
Phase 32Completed 1, Withdrawn 1

Follow Masked Hypertension: new trials by email Literature Review of Masked Hypertension trials Research Report on Masked Hypertension

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Real-World Validation of Huawei Wearable Technologies for Hypertension Risk Screening in Malaysia
Hypertension
Not yet recruitingSunway University5002026-10-012026-08-25
Screening for Masked Hypertension With Smart Wearable Devices (SMART)
smart wearable device - Masked Hypertension
UnknownJing Liu2002022-07-012022-06-08
Mechanism of Masked Hypertension - Intervention
Carvedilol, Amlodipine - Masked Hypertension
Phase 3WithdrawnUniversity of Alabama at Birmingham2021-07-012021-11-05
Wearable Blood Pressure Devices to Identify Masked Uncontrolled Hypertension.
Hypertension,Essential, Hypertension, Masked
UnknownNational Taiwan University Hospital Hsin-Chu Branch902020-11-262021-04-28
Masked Hypertensive Patients With Obstructive Sleep Apnea
CPAP treatment - Obstructive Sleep Apnea, Masked Hypertension
Not applicableCompletedSociedad Española de Neumología y Cirugía Torácica162020-04-012023-11-22
24-h-ambulatory Blood Pressure Monitoring and Pulse Wave Analysis in NAFLD Patients
24-h-ABPM - NAFLD; Hypertension, White-coat Hypertension, Masked Hypertension
UnknownUniversity Hospital of Cologne2002019-10-012020-09-10
MASked-unconTrolled hypERtension Management Based on Office BP or on Out-of-office (Ambulatory) BP Measurement
Optimization of antihypertensive treatment based on office BP, Optimization of antihypertensive treatment based on 24-hour ABPM - Masked Hypertension
Not applicableRecruitingIstituto Auxologico Italiano12402018-10-012026-03-30
Arterial Function After Two Different Physical Exercise Intensities in Prehypertension
Moderate intensity continuous training - session, High intensity interval training - session - Prehypertension, Masked Hypertension
Not applicableUnknownUniversity of Sao Paulo General Hospital222018-07-032023-01-31
Home Blood Pressure (HBP)-Guided Management of Hypertension in Stage 3-4 CKD
Home Blood Pressure Monitoring - Hypertension, Chronic Kidney Diseases
Not applicableUnknownAristotle University Of Thessaloniki702018-06-022022-02-28
Antihypertensive Treatment in Masked Hypertension
Allisartan Isoproxil, Placebo - Masked Hypertension
Phase 4CompletedYan Li3202017-02-142025-01-06
Prevalence of Masked Hypertension in Nephrological Patients
Comparison ABPM with OBPM - Masked Hypertension
UnknownWaid City Hospital, Zurich1002015-12-012021-10-28
Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes
"Liraglutide" and "Mitiglinide", "Metformin" and "Mitiglinide", "Mitiglinide" - Type 2 Diabetes, Overweight
Phase 4UnknownThird Affiliated Hospital of Third Military Medical University902015-05-012015-07-21
Stopping Antihypertensive Treatment amOng Hypertensive Patients in Primary Care (STOP-Trial)
Antihypertensive treatment will be stopped for 1 year unless hypertension recurrence - Hypertension
Not applicableCompletedCentral Hospital, Nancy, France4032015-03-102023-06-22
Treatment of Masked Hypertension
Antihypertensive medication intensification, Usual care - Masked Hypertension, Hypertension
Phase 3CompletedUniversity of Minnesota42014-06-012017-12-29
The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension
Gastrodia and Uncaria Drink - Masked Hypertension
Phase 4UnknownShanghai Institute of Hypertension4002014-03-012014-06-06
Cardiovascular Impact of Obstructive Sleep Apnea Treatment in Normotensive Patients
CPAP - Obstructive Sleep Apnea
Phase 4CompletedUniversity of Sao Paulo362008-08-012010-10-28
Psychosocial Factors and Cardiovascular Disease
Cardiovascular Diseases, Heart Diseases
CompletedColumbia University8931993-09-012024-07-18

Narrower conditions

Hypertension (6)  ·  White Coat Hypertension (4)  ·  Renal Insufficiency, Chronic (3)  ·  Prehypertension (2)  ·  Sleep Apnea, Obstructive (2)  ·  Cardiovascular Diseases (1)  ·  Diabetes Mellitus, Type 2 (1)  ·  Essential Hypertension (1)  ·  Heart Diseases (1)  ·  Hypertrophy, Left Ventricular (1)  ·  Motor Activity (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Obesity (1)  ·  Overweight (1)

Broader conditions

Vascular Diseases (17)  ·  Cardiovascular Diseases (16)  ·  Hypertension (11)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Chronic Disease (3)  ·  Disease Attributes (3)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Pathologic Processes (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Apnea (2)  ·  Dyssomnias (2)

Interventions

Amlodipine (1)  ·  Blood Pressure Monitoring, Ambulatory (1)  ·  Carvedilol (1)  ·  Continuous Positive Airway Pressure (1)  ·  Liraglutide (1)  ·  Metformin (1)  ·  allisartan isoproxil (1)  ·  gastrodin (1)  ·  mitiglinide (1)

Sponsors

Aristotle University Of Thessaloniki (1)  ·  Central Hospital, Nancy, France (1)  ·  Columbia University (1)  ·  Istituto Auxologico Italiano (1)  ·  Jing Liu (1)  ·  National Taiwan University Hospital Hsin-Chu Branch (1)  ·  Shanghai Institute of Hypertension (1)  ·  Sociedad Española de Neumología y Cirugía Torácica (1)  ·  Sunway University (1)  ·  Third Affiliated Hospital of Third Military Medical University (1)  ·  University Hospital of Cologne (1)  ·  University of Alabama at Birmingham (1)  ·  University of Minnesota (1)  ·  University of Sao Paulo (1)  ·  University of Sao Paulo General Hospital (1)

Countries

China (3)  ·  Brazil (2)  ·  United States (2)  ·  France (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Taiwan (1)  ·  Venezuela (1)

Top investigators

Andreas Schleich (1)  ·  Gianfranco Parati, MD (1)  ·  Jing Liu, MD (1)  ·  Joseph Schwartz, PhD (1)  ·  Luiz Bortolotto (1)  ·  Paul E Drawz, MD, MHS, MS (1)  ·  Yook Chin Chia (1)  ·  Zhiming Zhu, MD, PHD (1)

Results publications

PMID 26150543, PMID 30573476, PMID 33019798, PMID 38242946, PMID 39091669, PMID 40175098, PMID 40838798

NIH funding

2014 (1), P01HL047540 (1)